CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Cryoport, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$16.98+0.14 (+0.83%)

Close on Oct 19, 2026

Market cap: $856.52M
P/E (TTM): –
Dividend yield: –

Cryoport, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2016 2016-03-31	Q3 2016 2015-12-31	Q2 2016 2015-09-30	Q1 2016 2015-06-30	Q4 2015 2015-03-31	Q3 2015 2014-12-31
Revenue	49	48	45	44	45	41	41	38	40	37	57	56	57	63	60	60	64	52	56	57	56	53	48	11	9.39	9.77	9.24	9.58	8.46	6.65	5.69	5.29	4.63	4.02	0	1.46	1.44	1.43	1.56	0.98
Cost of Revenue	26	26	24	23	24	22	22	21	22	22	34	32	32	36	34	34	35	30	33	33	31	29	28	5.12	4.26	4.52	4.31	4.96	4.13	3.20	2.87	2.55	2.12	1.84	0.97	1.07	1.00	0.94	0.83	0.74
Gross Profit	23	22	22	21	21	19	19	17	18	15	-0.74	24	25	27	26	26	29	22	23	24	25	25	20	6.06	5.13	5.26	4.93	4.63	4.34	3.45	2.82	2.74	2.50	2.18	0	0.38	0.44	0.49	0.58	0.24
Research & Development	4.85	3.91	4.47	4.52	4.12	3.93	4.16	4.16	4.65	4.75	4.75	5.15	4.26	3.88	4.68	3.99	3.52	3.54	3.89	4.19	4.46	4.30	3.49	2.31	1.95	1.73	1.07	1.64	0.54	0.49	0.60	0.46	0.45	0.33	0.14	0.23	0.10	0.08	0.09	0.10
Selling, General & Admin	28	28	27	27	27	22	28	27	27	28	0.20	36	39	33	33	30	31	27	28	24	25	21	26	14	9.03	7.11	4.74	15	6.10	5.10	4.44	4.43	4.52	3.65	3.06	2.84	2.16	2.03	1.98	1.49
Selling & Marketing	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.68	3.29	3.08	2.61	5.96	2.84	2.41	1.99	1.82	1.85	1.58	1.25	1.13	0.90	0.88	–	–
General & Administrative	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	11	5.73	4.03	2.13	9.38	3.26	2.70	2.45	2.61	2.67	2.07	1.81	1.71	1.26	1.14	–	–
Operating Expenses	33	32	32	31	31	26	32	31	96	33	55	41	43	37	37	34	34	30	31	28	29	26	30	17	11	8.84	5.81	17	6.64	5.59	5.04	4.90	4.97	3.98	3.21	3.06	2.26	2.10	2.06	1.59
Operating Income	-10	-9.61	-10	-9.93	-9.65	-7.19	-13	-13	-78	-18	-55	-17	-18	-10	-11	-7.80	-5.25	-7.82	-8.36	-4.58	-3.75	-1.14	-9.85	-11	-5.85	-3.59	-0.88	-12	-2.30	-2.14	-2.22	-2.16	-2.47	-1.80	0	-2.68	-1.82	-1.62	-2.62	-1.36
Interest Expense	0.52	0.43	0.63	0.53	0.62	0.58	0.58	0.88	1.24	1.28	1.38	1.36	1.33	1.51	1.46	1.61	1.59	1.49	1.13	1.19	1.16	1.21	0.27	1.89	0.40	0.00	0.45	0.25	0.33	0.34	0.07	0	0	0	0.08	0.08	0.60	0.30	0.24	0.05
Other Non-Operating Income	2.29	0.29	2.64	3.40	-2.09	0.69	-4.56	18	1.68	2.58	6.64	4.11	0.61	4.96	3.08	2.54	-3.57	-5.24	-253	-0.93	-1.14	-1.35	-1.78	-0.71	0.09	-0.32	-0.94	0.13	0.12	0.09	-0.93	0.02	0.01	0.02	0.00	0.00	0.00	0.00	0.00	0.00
Asset Impairment Charges	–	–	–	–	–	–	0	0	64	–	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.03	-0.03	-3.09	-0.30	120	0.00	-0.09	-0.06	-0.11	-0.13	-0.68	-0.09	-0.11	-0.08	-0.23	-0.27	-0.21	-0.09	-0.42	-0.01	-0.04	-0.07	-0.17	-0.09	-0.04	-0.08	-0.12	-0.06	-0.05	-0.05	-0.23	-0.11	-0.04	-0.02	-0.13	0.00	-0.03	0	-0.01	0.00
Pretax Income	-7.75	-9.32	-7.40	-6.53	-12	-6.50	-17	4.24	-76	-15	-49	-13	-18	-5.08	-7.96	-5.26	-8.81	-13	-261	-5.50	-4.89	-2.49	-12	-11	-5.75	-3.91	-0.90	-12	-2.52	-2.39	-2.25	-2.14	-2.46	-2.68	-2.71	-2.76	-2.43	-1.92	-1.94	-1.41
Income Tax Expense	0.51	0.11	1.13	0.17	0.27	0.23	-0.13	0.32	0.07	0.11	-1.25	0.47	0.64	0.49	1.48	0.06	0.36	0.34	-0.88	1.02	0.50	1.04	-0.10	-0.03	0.05	0.03	0.05	0.00	0.01	0.00	0.00	0.00	0.01	0.00	0	0.00	0	0.00	0.00	0
Income from Continuing Operations	-8.26	-9.43	-8.52	-6.70	-12	-6.74	-17	3.92	-76	-15	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	0	-1.11	-3.12	-0.25	121	-5.24	-1.50	-3.12	-1.57	-3.86	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-8.26	-11	-12	-6.94	109	-12	-19	0.81	-78	-19	-62	-13	-18	-5.57	-9.44	-5.32	-9.18	-13	-260	-6.53	-5.39	-3.53	-12	-11	-5.80	-3.94	-0.95	-12	-2.53	-2.39	-2.26	-2.14	-2.47	–	–	–	–	–	–	–
Net Income	-8.26	-11	-12	-6.94	109	-12	-19	0.81	-78	-19	-62	-13	-18	-5.57	-9.44	-5.32	-9.18	-13	-260	-6.53	-5.39	-3.53	-12	-11	-5.80	-3.94	-0.95	-12	-2.53	-2.39	-2.26	-2.14	-2.47	-2.68	0	-3.00	-2.67	-6.61	-2.79	-1.41
Preferred Dividends	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.08	0.24	0.24	0.21	0.11	0.10
Net Income to Common	-10	-13	-14	-8.94	107	-14	-21	-1.20	-80	-21	-64	-15	-20	-7.57	-11	-7.32	-11	-15	-262	-8.53	-7.39	-5.72	-54	-11	-5.80	-3.94	-0.95	-12	-2.53	-2.39	–	–	–	–	-2.79	-3.00	-2.66	-6.61	-3.95	-2.00
EPS (Basic)(per share)	-0.20	-0.25	-0.27	-0.18	2.13	-0.28	-0.42	-0.02	-1.62	-0.43	-1.31	-0.31	-0.42	-0.16	-0.24	-0.15	-0.23	-0.31	-5.46	-0.18	-0.16	-0.13	-1.32	-0.29	-0.15	-0.11	-0.03	-0.35	-0.08	-0.08	-0.08	-0.07	-0.09	-0.10	0.00	-0.42	-0.41	-1.31	-0.26	-0.40
EPS (Diluted)(per share)	-0.20	-0.25	-0.27	-0.18	2.13	-0.28	-0.42	-0.02	-1.62	-0.43	-1.31	-0.31	-0.42	-0.16	-0.24	-0.15	-0.23	-0.31	-5.46	-0.18	-0.16	-0.13	-1.32	-0.29	-0.15	-0.11	-0.03	-0.35	-0.08	-0.08	-0.08	-0.07	-0.09	-0.10	0.00	-0.42	-0.41	-1.31	-0.26	-0.40
Shares Outstanding (Basic, Weighted)(shares)	50	50	50	50	50	50	50	49	49	49	49	49	49	48	49	49	49	50	48	46	46	44	40	39	38	38	36	36	31	30	29	29	28	27	11	7.23	6.51	5.06	5.02	5.00
Shares Outstanding (Diluted, Weighted)(shares)	50	50	50	50	50	50	50	49	49	49	49	49	49	48	49	49	49	50	48	46	46	44	40	39	38	38	36	36	31	30	29	29	28	27	11	7.23	6.51	5.06	5.02	5.00
EBITDA	-3.45	-3.21	-3.68	-3.52	-2.35	0.45	-4.85	-5.55	-70	-10	-48	-10.00	-12	-3.64	-4.90	-2.02	0.23	-2.45	-3.06	0.58	1.20	3.70	-2.48	-9.90	-5.00	-2.76	-0.05	-12	-1.81	-1.84	-1.96	-1.95	-2.27	-1.61	0.07	-2.61	-1.77	-1.57	-2.58	-1.31

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 47.1%
Operating margin: -21.2%
Net margin: -20.1%
Return on equity, FY2025: 17.3%

Financial strength

Current ratio: 2.08
Debt to equity: 0.00
Debt to assets: 0.1%
Cash to current liabilities: 121.8%

Valuation

P/E ratio: –
Price to sales: 4.59
Price to book: 1.75
Dividend yield: –